We are live on ! Find out more
HCA icon

HCA Healthcare

1,155 hedge funds and large institutions have $52.6B invested in HCA Healthcare in 2024 Q2 according to their latest regulatory filings, with 115 funds opening new positions, 455 increasing their positions, 407 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 115 | Existing positions closed: 72

12% more repeat investments, than reductions

Existing positions increased: 455 | Existing positions reduced: 407

3% more funds holding

Funds holding: 1,1261,155 (+29)

0.6% more ownership

Funds ownership: 61.94%62.53% (+0.6%)

4% less capital invested

Capital invested by funds: $54.6B → $52.6B (-$1.93B)

18% less funds holding in top 10

Funds holding in top 10: 3932 (-7)

20% less call options, than puts

Call options by funds: $498M | Put options by funds: $622M

Holders
1,155
Holders Change
+29
Holders Change %
+2.58%
% of All Funds
16.68%
Holding in Top 10
32
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-17.95%
% of All Funds
0.46%
New
115
Increased
455
Reduced
407
Closed
72
Calls
$498M
Puts
$622M
Net Calls
-$124M
Net Calls Change
-$296M
Name Holding Trade Value Shares
Change
Change in
Stake
YIH
401
Y-Intercept (HK)
Hong Kong
$3.45M +$3.49M +10,743 New
Robeco Institutional Asset Management
402
Robeco Institutional Asset Management
Netherlands
$3.43M +$315K +968 +10%
XT
403
XTX Topco
Cayman Islands
$3.41M +$2.52M +7,766 +273%
CCP
404
Cunning Capital Partners
North Carolina
$3.38M
GIS
405
Graphene Investments SAS
France
$3.37M
TCM
406
Teza Capital Management
Illinois
$3.36M +$643K +1,979 +23%
CAM
407
Carret Asset Management
New York
$3.32M +$81.2K +250 +2%
Cambridge Investment Research Advisors
408
Cambridge Investment Research Advisors
Iowa
$3.31M -$2.47M -7,596 -42%
Verition Fund Management
409
Verition Fund Management
Connecticut
$3.31M +$177K +545 +6%
AG
410
Ascent Group
Virginia
$3.28M -$73.4K -226 -2%
Bank Julius Baer & Co
411
Bank Julius Baer & Co
Switzerland
$3.28M +$2.98M +9,172 New
BHCM
412
Brevan Howard Capital Management
Jersey
$3.25M +$3.28M +10,110 New
NMERB
413
New Mexico Educational Retirement Board
New Mexico
$3.21M
DA
414
Detalus Advisors
Missouri
$3.21M
VSAM
415
Value Star Asset Management
Hong Kong
$3.21M
Carson Wealth (CWM LLC)
416
Carson Wealth (CWM LLC)
Nebraska
$3.17M +$304K +937 +10%
Fifth Third Bancorp
417
Fifth Third Bancorp
Ohio
$3.17M +$113K +347 +4%
OCAM
418
Onex Canada Asset Management
Ontario, Canada
$3.16M -$192K -591 -6%
AFS
419
Aft Forsyth & Sober
Florida
$3.13M
BCV
420
Banque Cantonale Vaudoise
Switzerland
$3.12M -$3.9K -12 -0.1%
CC
421
Centiva Capital
New York
$3.1M +$2.33M +7,181 +291%
HAI
422
Hennessy Advisors Inc
California
$3.08M -$65K -200 -2%
Allspring Global Investments
423
Allspring Global Investments
North Carolina
$3.05M -$44.8K -138 -1%
VI
424
Vestcor Inc
New Brunswick, Canada
$3.04M -$70.8K -218 -2%
William Blair & Company
425
William Blair & Company
Illinois
$3.04M +$324K +998 +12%

HCA Hedge Fund Activity: Q2 2024 in Review

1,155 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q2 2024, worth a combined $52.6B — down 3.5% from $54.6B a quarter earlier.

Buyers outnumbered sellers: 115 funds opened new HCA positions and 72 closed out — a net gain of 43 holders — while 455 added to existing stakes and 407 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $136M. The largest seller was Wellington Management Group, cutting an estimated $235M.

  • 1,155 institutional investors held HCA Healthcare (HCA) as of Q2 2024, up from 1,126 in Q1 2024.
  • Funds reported $52.6B of HCA Healthcare stock for Q2 2024, down 3.5% quarter-over-quarter.
  • 115 funds opened new HCA Healthcare positions in Q2 2024 and 72 closed out, a net change of +43 holders.
  • The largest HCA Healthcare buyer in Q2 2024 was Goldman Sachs, an estimated $136M added.
  • The largest HCA Healthcare seller in Q2 2024 was Wellington Management Group, an estimated $235M sold.

Based on aggregated 13F filings for Q2 2024.